CD44 and breast cancer: An important effect of loss of PRLR expression in HR + MCF7 breast cancer cells were the promotion of luminal-to-basal conversion as measured by the loss of expression of the luminal markers CK18 and ER and the gain in stem cell marker CD44 expression.